ASSOCIATION BETWEEN TEMPOROMANDIBULAR DISORDERS AND SLEEP DISORDERS
Gnathology TMD
2 other identifiers
observational
100
1 country
2
Brief Summary
ASSOCIATION BETWEEN TEMPOROMANDIBULAR DISORDERS AND SLEEP DISORDERS
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2025
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedFirst Posted
Study publicly available on registry
May 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedMay 16, 2025
May 1, 2025
8 months
March 28, 2025
May 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Primary Outcome
The main aim of the present study is to evaluate the prevalence of TMDs in patients with sleep disorders. This population was selected in order to contribute, in the context of scientific research, to the investigation into the association between temporomandibular disorders and sleep disorders, which include all those disorders that compromise both the quantity and quality of sleep with repercussions important on general health and quality of life, like: * Insomnia * Hypersomnia * Restless legs syndrome * REM sleep behavior disorder * Narcolepsy * Obstructive sleep apnea syndrome (OSAS) * Primary snoring * REM parasomnias (Sleepwalking, arousal disorders, excessive daytime sleepiness and night terrors) * Nocturnal epilepsy Patients with sleep disorders may be recruited in the observational study conducted by the University's Department of Dentistry Vita-Salute San Raffaele and the Neurology-sleep disorders unit of the San Raffaele Hospital in Turro, aimed at evaluating the prevalence of T
at enrollment
Secondary Outcomes (1)
Secondary Outcome
at enrollment
Study Arms (1)
patients with TMD
Temporomandibular disorder (TMD), a common cause of chronic orofacial pain, is a group of painful and/or dysfunctional conditions of the masticatory muscles, temporomandibular joint (TMJ) and associated structures.
Interventions
The diagnostic questionnaires will be administered and the participants' responses will subsequently be analyzed, evaluating the presence of temporomandibular disorders (DTMs) in patients with sleep disorders. The questionnaires will be administered to patients with a previous diagnosis of sleep disorder carried out at a specialist centre, consecutively belonging to the outpatient clinics of both centers U.O of Neurology-Sleep Disorders Center and U.O of Dentistry.
Eligibility Criteria
The study population must include Female and Male over 18 y.o with sleep disorders that meet inclusion and exclusion criteria.
You may qualify if:
- Age \>18 years
- Famale and Male
- Signature of the privacy information form
- Signature of the informed consent form of the protocol
- Subjects capable of understanding and wanting
- Subjects suffering from a sleep disorder (Insomnia,Hypersomnia,Restless legs syndrome,REM sleep behavior disorder,Narcolepsy,Obstructive sleep apnea syndrome (OSAS),Primary snoring, REM parasomnias,Nocturnal epilepsy)
You may not qualify if:
- Physical trauma to the head and neck area
- Painful oral pathologies (e.g. pulpitis, tooth fractures, tooth abscesses, tooth decay, canker sores and mucosal wounds)
- Recent dental treatments that may cause pain (e.g. tooth extraction, tooth root canal)
- Use of oral contraceptives
- Subjects not capable of understanding and wanting
- Patients suffering from neurological pathologies that may interfere with the completion of the questionnaires (ES dementia) or psychiatric pathologies or drug use as per DSM-5 criteria (including schizophrenia, bipolar, major depression, substance abuse, personality disorders).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
IRCCS San Raffaele Hospital
Milan, Italy, 20132, Italy
IRCCS Ospedale San Raffaele Turro
Milan, Milano, 20127, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
March 28, 2025
First Posted
May 16, 2025
Study Start
April 1, 2025
Primary Completion
December 1, 2025
Study Completion
April 1, 2026
Last Updated
May 16, 2025
Record last verified: 2025-05